B
Brendan J. Barrett
Researcher at Memorial University of Newfoundland
Publications - 166
Citations - 9666
Brendan J. Barrett is an academic researcher from Memorial University of Newfoundland. The author has contributed to research in topics: Kidney disease & Renal function. The author has an hindex of 43, co-authored 161 publications receiving 9178 citations. Previous affiliations of Brendan J. Barrett include St. John's University & Copenhagen University Hospital.
Papers
More filters
Journal ArticleDOI
Contrast material-induced renal failure in patients with diabetes mellitus, renal insufficiency, or both. A prospective controlled study.
Patrick S. Parfrey,Sheila M. Griffiths,Brendan J. Barrett,Michael D. Paul,Margot Genge,John Withers,Nadir R. Farid,P J McManamon +7 more
TL;DR: It is concluded that there is little risk of clinically important nephrotoxicity attributable to contrast material for patients with diabetes and normal renal function or for nondiabetic patients with preexisting renal insufficiency.
Journal ArticleDOI
Left ventricular mass index increase in early renal disease: impact of decline in hemoglobin.
Adeera Levin,Christopher R. Thompson,Jean Ethier,Euan Carlisle,Sheldon W. Tobe,David C. Mendelssohn,Ellen Burgess,Kailash Jindal,Brendan J. Barrett,Joel Singer,Ognjenka Djurdjev +10 more
TL;DR: There remains a critical need to establish optimal therapeutic strategies and targets to improve clinical outcomes in patients with progressive renal disease, and the important modifiable risk factors are defined.
Journal ArticleDOI
Metaanalysis of the relative nephrotoxicity of high- and low-osmolality iodinated contrast media.
Brendan J. Barrett,Euan Carlisle +1 more
TL;DR: Use of LOCM may be beneficial in patients with existing renal failure, and the pooled odds of a rise in SCr level of more than 44 mumol/L with LOCM was three times that after HOCM.
Journal ArticleDOI
Preventing Nephropathy Induced by Contrast Medium
TL;DR: A 71-year-old man with type 2 diabetes and hypertension is referred for coronary angiography and his medications include metformin and a thiazide, and the risk that an angiographic contrast medium will worsen his kidney function is high.
Journal ArticleDOI
Guidelines for the management of chronic kidney disease
Adeera Levin,Brenda R. Hemmelgarn,Bruce F. Culleton,Sheldon W. Tobe,Philip A. McFarlane,Marcel Ruzicka,Kevin D. Burns,Braden J. Manns,Colin T. White,Francoise Madore,Louise Moist,Scott Klarenbach,Brendan J. Barrett,Robert N. Foley,Kailash Jindal,Peter A. Senior,Neesh Pannu,Sabin Shurraw,Ayub Akbari,Adam Cohn,Martina Reslerova,Vinay Deved,David C. Mendelssohn,Gihad Nesrallah,Joanne Kappel,Marcello Tonelli +25 more
TL;DR: New guidelines for the management of chronic kidney disease have been developed by the Canadian Society of Nephrology and describe key aspects of the management.